Clinical Trial Update: Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy

View source ↗

Summary

A completed clinical trial evaluating imaging biomarkers (FDG PET/CT, diffusion-weighted MRI, and dynamic contrast-enhanced MRI) as predictors of chemotherapy o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Non-small Cell Lung Cancer | Status: COMPLETED